Delivery of Mesenchymal Stem Cells During Hypothermic Machine Perfusion in a Translational Kidney Perfusion Study

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 May 11

PMID 38732257

Authors

Natalie Vallant

Nienke Wolfhagen

Bynvant Sandhu

Karim Hamaoui

Vassilios Papalois

Affiliations

Soon will be listed here.

Abstract

In transplantation, hypothermic machine perfusion (HMP) has been shown to be superior to static cold storage (SCS) in terms of functional outcomes. Ex vivo machine perfusion offers the possibility to deliver drugs or other active substances, such as Mesenchymal Stem Cells (MSCs), directly into an organ without affecting the recipient. MSCs are multipotent, self-renewing cells with tissue-repair capacities, and their application to ameliorate ischemia- reperfusion injury (IRI) is being investigated in several preclinical and clinical studies. The aim of this study was to introduce MSCs into a translational model of hypothermic machine perfusion and to test the efficiency and feasibility of this method. Methods: three rodent kidneys, six porcine kidneys and three human kidneys underwent HMP with 1-5 × 10 labelled MSCs within respective perfusates. Only porcine kidneys were compared to a control group of 6 kidneys undergoing HMP without MSCs, followed by mimicked reperfusion with whole blood at 37 °C for 2 h for all 12 kidneys. Reperfusion perfusate samples were analyzed for levels of NGAL and IL-β by ELISA. Functional parameters, including urinary output, oxygen consumption and creatinine clearance, were compared and found to be similar between the MSC treatment group and the control group in the porcine model. IL-1β levels were higher in perfusate and urine samples in the MSC group, with a median of 285.3 ng/mL (IQR 224.3-407.8 ng/mL) vs. 209.2 ng/mL (IQR 174.9-220.1), = 0.51 and 105.3 ng/mL (IQR 71.03-164.7 ng/mL) vs. 307.7 ng/mL (IQR 190.9-349.6 ng/mL), = 0.16, respectively. MSCs could be traced within the kidneys in all models using widefield microscopy after HMP. The application of Mesenchymal Stem Cells in an ex vivo hypothermic machine perfusion setting is feasible, and MSCs can be delivered into the kidney grafts during HMP. Functional parameters during mimicked reperfusion were not altered in treated kidney grafts. Changes in levels of IL-1β suggest that MSCs might have an effect on the kidney grafts, and whether this leads to a positive or a negative outcome on IRI in transplantation needs to be determined in further experiments.

References

Fang X, Neyrinck A, Matthay M, Lee J . Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1. J Biol Chem. 2010; 285(34):26211-22. PMC: 2924032. DOI: 10.1074/jbc.M110.119917. View

Vallant N, Wolfhagen N, Sandhu B, Hamaoui K, Cook T, Pusey C . A Comparison of Pulsatile Hypothermic and Normothermic Ex Vivo Machine Perfusion in a Porcine Kidney Model. Transplantation. 2021; 105(8):1760-1770. DOI: 10.1097/TP.0000000000003599. View

Jochmans I, Moers C, Smits J, Leuvenink H, Treckmann J, Paul A . Machine perfusion versus cold storage for the preservation of kidneys donated after cardiac death: a multicenter, randomized, controlled trial. Ann Surg. 2010; 252(5):756-64. DOI: 10.1097/SLA.0b013e3181ffc256. View

Franquesa M, Hoogduijn M, Reinders M, Eggenhofer E, Engela A, Mensah F . Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: lessons learned from first clinical trials. Transplantation. 2013; 96(3):234-8. PMC: 3737392. DOI: 10.1097/TP.0b013e318298f9fa. View

Pool M, Eertman T, Sierra Parraga J, t Hart N, Roemeling-van Rhijn M, Eijken M . Infusing Mesenchymal Stromal Cells into Porcine Kidneys during Normothermic Machine Perfusion: Intact MSCs Can Be Traced and Localised to Glomeruli. Int J Mol Sci. 2019; 20(14). PMC: 6678394. DOI: 10.3390/ijms20143607. View

Erpicum P, Rowart P, Poma L, Krzesinski J, Detry O, Jouret F . Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in rats. Sci Rep. 2017; 7(1):8687. PMC: 5561049. DOI: 10.1038/s41598-017-08726-z. View

Roemeling-van Rhijn M, Weimar W, Hoogduijn M . Mesenchymal stem cells: application for solid-organ transplantation. Curr Opin Organ Transplant. 2011; 17(1):55-62. DOI: 10.1097/MOT.0b013e32834ee676. View

Moers C, Smits J, Maathuis M, Treckmann J, Van Gelder F, Napieralski B . Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med. 2009; 360(1):7-19. DOI: 10.1056/NEJMoa0802289. View

Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I . Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008; 371(9624):1579-86. DOI: 10.1016/S0140-6736(08)60690-X. View

10.

Deng R, Gu G, Wang D, Tai Q, Wu L, Ju W . Machine perfusion versus cold storage of kidneys derived from donation after cardiac death: a meta-analysis. PLoS One. 2013; 8(3):e56368. PMC: 3594243. DOI: 10.1371/journal.pone.0056368. View

11.

Hoogduijn M, Roemeling-van Rhijn M, Engela A, Korevaar S, Mensah F, Franquesa M . Mesenchymal stem cells induce an inflammatory response after intravenous infusion. Stem Cells Dev. 2013; 22(21):2825-35. DOI: 10.1089/scd.2013.0193. View

12.

Reinders M, Fibbe W, Rabelink T . Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation. Nephrol Dial Transplant. 2009; 25(1):17-24. DOI: 10.1093/ndt/gfp552. View

13.

Liu X, Cai J, Jiao X, Yu X, Ding X . Therapeutic potential of mesenchymal stem cells in acute kidney injury is affected by administration timing. Acta Biochim Biophys Sin (Shanghai). 2017; 49(4):338-348. DOI: 10.1093/abbs/gmx016. View

14.

Assis A, Carvalho J, Jacoby B, Ferreira R, Castanheira P, Diniz S . Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart. Cell Transplant. 2009; 19(2):219-30. DOI: 10.3727/096368909X479677. View

15.

Herrera M, Bussolati B, Bruno S, Fonsato V, Romanazzi G, Camussi G . Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med. 2004; 14(6):1035-41. View

16.

Motegi S, Ishikawa O . Mesenchymal stem cells: The roles and functions in cutaneous wound healing and tumor growth. J Dermatol Sci. 2016; 86(2):83-89. DOI: 10.1016/j.jdermsci.2016.11.005. View

17.

OCallaghan J, Morgan R, Knight S, Morris P . Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes. Br J Surg. 2013; 100(8):991-1001. DOI: 10.1002/bjs.9169. View

18.

Hamaoui K, Gowers S, Boutelle M, Cook T, Hanna G, Darzi A . Organ Pretreatment With Cytotopic Endothelial Localizing Peptides to Ameliorate Microvascular Thrombosis and Perfusion Deficits in Ex Vivo Renal Hemoreperfusion Models. Transplantation. 2016; 100(12):e128-e139. DOI: 10.1097/TP.0000000000001437. View

19.

Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-7. DOI: 10.1080/14653240600855905. View

20.

Cha J, Shin E, Sung J, Moon G, Kim E, Cho Y . Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells. Sci Rep. 2018; 8(1):1171. PMC: 5775399. DOI: 10.1038/s41598-018-19211-6. View